{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:23:56Z","timestamp":1787207036046,"version":"build-2736575974"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) and Alzheimer\u2019s disease (AD) are age-related disorders with a complex epidemiological association and limited therapeutic options. Identifying shared molecular drivers may reveal new treatment targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify common transcriptomic signatures between PCa and AD and validate the role of interleukin-11 (IL11) as a functional comorbidity factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multi-cohort transcriptomic datasets (GSE48350, GSE5281 and GSE28146 for AD; TCGA-PRAD, DKFZ2018 and MSKCC for PCa) were analyzed. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were performed, followed by a two-tier machine learning pipeline (Random Forest and LASSO Cox regression) to screen overlapping genes. Immune infiltration was evaluated by CIBERSORT and single-cell transcriptomics for PCa. The functional role of IL11 was assessed in RM-1 murine and DU145 human PCa cells using colony formation, wound healing, Transwell assays, and immunocompetent C57BL\/6 orthotopic and subcutaneous xenograft models. The cognitive effects of IL11 were evaluated using Morris water maze (MWM) tests, and the neuropathological changes were assessed by detecting hippocampal amyloid-\u03b2 (A\u03b2) deposition. Additionally, a cross-sectional analysis was performed in a population cohort (n=215) to investigate the associations between IL11 levels and AD pathological biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 455 shared candidate genes were identified, and a 10-gene signature (NDRG4, ISG15, IL11, ENO2, DYNC1I1, DNASE1, ATP6V1G2, ATCAY, ANLN, AGAP9) was established. The risk score effectively stratified PCa patients with poor progression-free interval (log-rank P &amp;lt; 0.001; AUC for 1-,3-,5-year = 0.78,0.73,0.70), validated in two external cohorts (DKFZ2018, MSKCC). IL11 was the top candidate and was significantly upregulated in both diseases. High IL11 expression correlated with an immunosuppressive microenvironment, characterized by increased M2 macrophages and regulatory T cells, and with higher tumor mutation burden. Single-cell analysis localized IL11 to a subset of cancer-associated fibroblasts.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , IL11 treatment enhanced PCa cell proliferation, migration, and invasion.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , intraperitoneal IL11 accelerated PCa tumor growth in mice. In the MWM test, IL11-treated mice exhibited significantly longer escape latencies and fewer platform crossings, which were accompanied by increased hippocampal A\u03b2 deposition, suggesting that IL11 induced cognitive dysfunction. Cross-sectional cohort analyses further linked higher serum IL11 to reduced CSF A\u03b242 and elevated p-tau181.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IL11 acts as a shared risk factor related to PCa progression and cognitive decline in AD, representing a convergent molecular pathway and a potential therapeutic target for both age-related diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1911726","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:28:23Z","timestamp":1787203703000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer\u2019s disease using integrated bioinformatics and machine learning"],"prefix":"10.3389","volume":"17","author":[{"given":"Mengxue","family":"Wang","sequence":"first","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Qian","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyao","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Chu","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]},{"name":"Department of Pathology, Zhongda Hospital, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengrong","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caichen","family":"Luo","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiejunhao","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Han","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]},{"name":"Department of Urology, Zhongda Hospital, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipu","family":"Mao","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]},{"name":"Department of Urology, Zhongda Hospital, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University","place":["Nanjing, China"]},{"name":"Department of Urology, Zhongda Hospital, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14070774","article-title":"Interplay between aging and tau pathology in Alzheimer's disease: Mechanisms and translational perspectives","volume":"14","author":"Alrouji","year":"2025","journal-title":"Antioxid (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149774","article-title":"Therapy-induced senescence in prostate cancer: mechanisms, therapeutic strategies, and clinical implications","volume":"972","author":"Bacca","year":"2025","journal-title":"Gene"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.353129.125","article-title":"Cancer mortality and senescence: Is redox therapy an option","volume":"39","author":"Kuang","year":"2025","journal-title":"Genes Dev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106270","article-title":"Imaging markers of neuroinflammation in aging and Alzheimer's disease and related dementia: A comprehensive review","volume":"176","author":"Chaudhary","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12979-025-00529-5","article-title":"Systemic inflammation as a central player in the initiation and development of Alzheimer's disease","volume":"22","author":"Bayraktaroglu","year":"2025","journal-title":"Immun Ageing"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn8709","article-title":"Androgen deprivation therapy exacerbates Alzheimer's-associated cognitive decline via increased brain immune cell infiltration","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci Adv"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.12.006","article-title":"The cost of Alzheimer's disease in China and re-estimation of costs worldwide","volume":"14","author":"Jia","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27062900","article-title":"Locus- and gene-level insights into the inverse association between Alzheimer's disease and cancer","volume":"27","author":"Debnath","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1354528","article-title":"Causal relationship between Alzheimer's disease and prostate cancer: a bidirectional Mendelian randomization analysis","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.04.001","article-title":"Associations between prostate cancer and dementia: a nationwide study in Sweden","volume":"8","author":"Crump","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23490","DOI":"10.1038\/s41598-025-08279-6","article-title":"Risk of Alzheimer's disease and Parkinson's disease following androgen deprivation therapy in a real world nationwide cohort","volume":"15","author":"Jeon","year":"2025","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030635","article-title":"Treatment of advanced prostate cancer-a review of current therapies and future promise","volume":"8","author":"Sumanasuriya","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2025.1953","article-title":"Unlocking artificial intelligence, machine learning and deep learning to combat therapeutic resistance in metastatic castration-resistant prostate cancer: a comprehensive review","volume":"19","author":"Ejaz","year":"2025","journal-title":"Ecancermedicalscience"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060751","article-title":"Immune checkpoint inhibitor therapy for prostate cancer: present and future prospectives","volume":"15","author":"Rai","year":"2025","journal-title":"Biomolecules"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70098","article-title":"Alzheimer's disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176230","article-title":"Targets, trials and tribulations in Alzheimer therapeutics","volume":"962","author":"Gharat","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-026-13829-7","article-title":"A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease","volume":"273","author":"Hafez","year":"2026","journal-title":"J Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166524","article-title":"Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: a current update on molecular mechanisms and combination therapy","volume":"1868","author":"Poddar","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ydbio.2014.03.022","article-title":"Peroxisomal membrane channel Pxmp2 in the mammary fat pad is essential for stromal lipid homeostasis and for development of mammary gland epithelium in mice","volume":"391","author":"Vapola","year":"2014","journal-title":"Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806883105","article-title":"Gene expression changes in the course of normal brain aging are sexually dimorphic","volume":"105","author":"Berchtold","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00208.2006","article-title":"Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain","volume":"28","author":"Liang","year":"2007","journal-title":"Physiol Genomics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.11.001","article-title":"2014 update of the Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception","volume":"11","author":"Weiner","year":"2015","journal-title":"Alzheimers Dement"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.889647","article-title":"Technical performance evaluation of Olink proximity extension assay for blood-based biomarker discovery in longitudinal studies of Alzheimer's disease","volume":"13","author":"Carlyle","year":"2022","journal-title":"Front Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1-42) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement"},{"key":"B31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"Shaw","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","article-title":"How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer","volume":"24","author":"Stultz","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s40001-025-02755-5","article-title":"Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis","volume":"30","author":"Zhou","year":"2025","journal-title":"Eur J Med Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107966","article-title":"Interleukin-11: A central integrative hub driving pathological progression from pulmonary inflammation and fibrosis to cancer","volume":"221","author":"Yu","year":"2025","journal-title":"Pharmacol Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1042\/bcj20220160","article-title":"Understanding interleukin 11 as a disease gene and therapeutic target","volume":"480","author":"Cook","year":"2023","journal-title":"Biochem J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/s41467-021-22450-3","article-title":"Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer","volume":"12","author":"Nishina","year":"2021","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-70645-3","article-title":"Ultra-precision deconvolution of spatial transcriptomics decodes immune heterogeneity and fate-defining programs in tissues","volume":"17","author":"Xu","year":"2026","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07701-9","article-title":"Inhibition of IL-11 signalling extends mammalian healthspan and lifespan","volume":"632","author":"Widjaja","year":"2024","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/bju.14666","article-title":"Androgen deprivation therapy for prostate cancer and risk of dementia","volume":"124","author":"Robinson","year":"2019","journal-title":"BJU Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14540","article-title":"Unraveling the bidirectional link between cancer and dementia and the impact of cancer therapies on dementia risk: A systematic review and meta-analysis","volume":"21","author":"Ma","year":"2025","journal-title":"Alzheimers Dement"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251318003","article-title":"Androgen deprivation therapy and dementia risk: an updated and dose-response meta-analysis","volume":"104","author":"Zhu","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw1237","article-title":"Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis","volume":"11","author":"Ng","year":"2019","journal-title":"Sci Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041818-011649","article-title":"Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation","volume":"71","author":"Cook","year":"2020","journal-title":"Annu Rev Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/srep38408","article-title":"Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11\/IL-11R\/STAT3 signaling pathway","volume":"6","author":"Tao","year":"2016","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2022.01331","article-title":"A brief summary regarding the roles of interleukin-11 in neurological diseases","volume":"16","author":"Airapetov","year":"2022","journal-title":"Biosci Trends"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0737-6","article-title":"Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration","volume":"255","author":"Galimberti","year":"2008","journal-title":"J Neurol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221007120","article-title":"IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system","volume":"120","author":"Seyedsadr","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319200","article-title":"STAT3 activation through IL-6\/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis","volume":"69","author":"Heichler","year":"2020","journal-title":"Gut"},{"key":"B52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-024-02962-8","article-title":"Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1\/STAT4 pathway","volume":"43","author":"Cheng","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0002-9440(10)63940-5","article-title":"Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma","volume":"158","author":"Campbell","year":"2001","journal-title":"Am J Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1134\/s0026893323010028","article-title":"Interleukin-11 in pathologies of the nervous system","volume":"57","author":"Airapetov","year":"2023","journal-title":"Mol Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29344","article-title":"Targeting the interleukin-11 receptor \u03b1 in metastatic prostate cancer: a first-in-man study","volume":"121","author":"Pasqualini","year":"2015","journal-title":"Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1911726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:28:25Z","timestamp":1787203705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1911726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2026.1911726"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1911726","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1911726"}}